Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 66 positions · Total reported value $6.72B · Top-10 concentration 40.5% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.3% · 18 new · 15 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Deep Track Capital, LP disclosed 66 equity positions with a combined reported value of $6.72B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were GH ($509.10M), IMVT ($359.91M), GPCR ($254.40M). By sector, the heaviest allocations are Health Care 95.4%, Other 4.6%. Versus the prior quarter, allocation shifted toward Health Care (+26.2pp) and away from Other (-26.2pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 59% of names.

The largest new positions opened in Q2 2026 were ALNY ($248.35M), COAG ($132.30M), GHRS ($89.60M).

Of the 15 positions fully exited versus the prior quarter, the largest were XBI ($1.28B), APLS ($182.34M), CNTA ($125.44M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • ALNY ALNYLAM PHARMACEUTICALS · $248.35M
  • COAG HEMAB THERAPEUTICS HOLDINGS · $132.30M
  • GHRS GH RESEARCH PLC · $89.60M
  • UTHR UNITED THERAPEUTICS CORP DEL COM · $66.98M
  • AVTX AVALO THERAPEUTICS INC · $66.71M
  • ALT ALTIMMUNE INC · $58.52M
  • WGS GENEDX HOLDINGS CORP · $48.05M
  • HROW HARROW INC · $41.15M

Fully Exited (vs previous quarter)

  • XBI STATE STREET SPDR S&P BIOTECH ETF · prev qtr: $1.28B
  • APLS APELLIS PHARMACEUTICALS INC · prev qtr: $182.34M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $125.44M
  • BBIO BRIDGEBIO PHARMA INC · prev qtr: $62.49M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $56.61M
  • GERN GERON CORP · prev qtr: $47.26M
  • ANIP ANI PHARMACEUTICALS INC · prev qtr: $46.14M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $36.12M

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 95.4%
Other 4.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 3.39M $509.10M 7.58%
7.58%
Add
2 9.34M $359.91M 5.36%
5.36%
Reduce
3 4.74M $254.40M 3.79%
3.79%
Add
4 4.30M $249.96M 3.72%
3.72%
Hold
5 825.00K $248.35M 3.70%
3.70%
New
6 2.00M $245.88M 3.66%
3.66%
Add
7 3.67M $230.79M 3.44%
3.44%
Add
8 1.78M $220.24M 3.28%
3.28%
Add
9 4.00M $209.58M 3.12%
3.12%
Add
10 19.69M $193.32M 2.88%
2.88%
Hold
11 3.31M $189.25M 2.82%
2.82%
Add
12 7.74M $187.69M 2.79%
2.79%
Add
13 1.93M $183.30M 2.73%
2.73%
Reduce
14 6.35M $178.65M 2.66%
2.66%
Reduce
15 2.20M $174.44M 2.60%
2.60%
Add
16 12.16M $172.09M 2.56%
2.56%
Hold
17 4.00M $171.64M 2.56%
2.56%
Reduce
18 700.00K $171.34M 2.55%
2.55%
Reduce
19 7.00M $136.27M 2.03%
2.03%
Add
20 3.60M $132.30M 1.97%
1.97%
New
21 4.20M $131.29M 1.96%
1.96%
Add
22 2.75M $129.36M 1.93%
1.93%
Reduce
23 1.83M $125.27M 1.86%
1.86%
Add
24 4.10M $121.73M 1.81%
1.81%
Add
25 3.73M $111.38M 1.66%
1.66%
Add
26 2.94M $109.37M 1.63%
1.63%
Add
27 3.35M $108.82M 1.62%
1.62%
Hold
28 1.73M $95.64M 1.42%
1.42%
Reduce
29 3.33M $89.60M 1.33%
1.33%
New
30 3.00M $82.41M 1.23%
1.23%
Reduce
31 2.00M $77.40M 1.15%
1.15%
Add
32 14.42M $75.98M 1.13%
1.13%
Add
33 123.62K $66.98M 1.00%
1.00%
New
34 3.61M $66.71M 0.99%
0.99%
New
35 3.59M $66.00M 0.98%
0.98%
Add
36 700.00K $59.63M 0.89%
0.89%
Reduce
37 19.25M $58.52M 0.87%
0.87%
New
38 4.00M $53.60M 0.80%
0.80%
Add
39 9.35M $49.44M 0.74%
0.74%
Hold
40 6.27M $49.25M 0.73%
0.73%
Hold
41 700.00K $48.05M 0.72%
0.72%
New
42 969.00K $41.15M 0.61%
0.61%
New
43 2.49M $37.23M 0.55%
0.55%
Hold
44 3.57M $35.61M 0.53%
0.53%
Hold
45 1.00M $34.32M 0.51%
0.51%
Add
46 1.50M $33.31M 0.50%
0.50%
Reduce
47 2.77M $28.61M 0.43%
0.43%
New
48 5.88M $27.45M 0.41%
0.41%
Reduce
49 3.71M $25.72M 0.38%
0.38%
New
50 6.00M $25.56M 0.38%
0.38%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 60% R 60% F1 60% (modelled on 2026-Q1; 6/10 hit)

Low-confidence forecast This fund replaces about 32% of its Top-10 each quarter and backtests at F1 69% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 69% · recall 69% · F1 69% · avg rank error 3.2 · Top-10 turnover 32%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 40% 40% 40% INSM · SWTX · GH · ITCI · ARGX · ALKS · PLRX · DVAX · VRDN · AXSM SWTX · AMGN · APGE · INSM · DYN · ALNY · GH · ARGX · NTLA · OCUL
2024-Q2 80% 80% 80% SWTX · AMGN · APGE · DYN · NTLA · GH · OCUL · INSM · ALNY · ARGX AMGN · ARGX · AXSM · DYN · SWTX · INSM · GH · DVAX · ALNY · NTLA
2024-Q3 70% 70% 70% AMGN · ARGX · AXSM · DYN · SWTX · GH · DVAX · INSM · NTLA · ITCI ARGX · DVAX · GH · APLS · IMVT · SWTX · DYN · ITCI · OCUL · NTLA
2024-Q4 70% 70% 70% ARGX · DVAX · APLS · IMVT · GH · ITCI · SWTX · DYN · OCUL · NTLA DVAX · GH · ITCI · IMVT · APLS · SWTX · CYTK · OCUL · VRDN · PLRX
2025-Q1 70% 70% 70% DVAX · GH · ITCI · IMVT · APLS · CYTK · SWTX · OCUL · VRDN · GPCR ITCI · GH · DVAX · IMVT · PTGX · IONS · AKRO · CYTK · APLS · OCUL
2025-Q2 80% 80% 80% ITCI · DVAX · GH · IMVT · PTGX · IONS · AKRO · CYTK · APLS · BBIO GH · IONS · PTGX · DVAX · INSM · AKRO · IMVT · OCUL · APLS · CYTK
2025-Q3 80% 80% 80% IONS · GH · PTGX · INSM · AKRO · DVAX · IMVT · OCUL · APLS · CYTK GH · IONS · CYTK · AKRO · APLS · TARS · IMVT · DVAX · OCUL · ETNB
2025-Q4 60% 60% 60% GH · CYTK · IONS · TARS · AKRO · APLS · IMVT · DVAX · ETNB · OCUL XBI · IMVT · GH · GPCR · TARS · DVAX · CYTK · AXSM · APLS · PCVX
2026-Q1 80% 80% 80% XBI · IMVT · GPCR · GH · TARS · DVAX · AXSM · CYTK · PCVX · APLS XBI · GH · IMVT · TARS · PCVX · GPCR · AXSM · APLS · OCUL · VERA
2026-Q2 ★ 60% 60% 60% XBI · GH · IMVT · PCVX · TARS · GPCR · AXSM · OCUL · VERA · APLS GH · IMVT · GPCR · PCVX · ALNY · MANE · TARS · NUVL · ALKS · OCUL

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Deep Track Capital, LP buy in 2026-Q2?

In its 2026-Q2 13F filing, Deep Track Capital, LP reported 66 equity positions worth $6.72B in aggregate; its largest disclosed positions were GH ($509.10M), IMVT ($359.91M), GPCR ($254.40M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $6.72B of long equity holdings across 66 positions as of 2026-Q2. Top-10 holdings account for 40.5% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →